279 related articles for article (PubMed ID: 20223130)
1. [Referral criteria for benign prostatic hyperplasia in primary care.Sociedad Española de Médicos de Atención Primaria, Sociedad Española de Medicina General, Sociedad Española de Medicina de Familia y Comunitaria, Asociación Española de Urología].
Castiñeiras Fernández J; Cozar Olmo JM; Fernández-Pro A; Martín JA; Brenes Bermúdez FJ; Naval Pulido E; Molero JM; Pérez Morales D; ; ; ;
Actas Urol Esp; 2010 Jan; 34(1):24-34. PubMed ID: 20223130
[TBL] [Abstract][Full Text] [Related]
2. [Referral criteria for benign prostatic hyperplasia in primary care].
Molero JM; Pérez Morales D; Brenes Bermúdez FJ; Naval Pulido E; Fernández-Pro A; Martín JA; Castiñeiras Fernández J; Cozar Olmo JM
Aten Primaria; 2010 Jan; 42(1):36-46. PubMed ID: 19913947
[TBL] [Abstract][Full Text] [Related]
3. [Urine incontinence referral criteria for primary care].
Brenes Bermúdez FJ; Cozar Olmo JM; Esteban Fuertes M; Fernández-Pro Ledesma A; Molero García JM; ; ; ;
Aten Primaria; 2013 May; 45(5):263-73. PubMed ID: 23623519
[TBL] [Abstract][Full Text] [Related]
4. [Urine incontinence referral criteria for primary care].
Brenes Bermúdez FJ; Cozar Olmo JM; Esteban Fuertes M; Fernández-Pro Ledesma A; Molero García JM
Semergen; 2013; 39(4):197-207. PubMed ID: 23726731
[TBL] [Abstract][Full Text] [Related]
5. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
[TBL] [Abstract][Full Text] [Related]
6. [Factors determining treatment strategies for patients with benign prostatic hyperplasia. The DUO study].
Fourcade RO; Picot MC; Gaudin AF; Texier N; Slama A
Presse Med; 2007 May; 36(5 Pt 1):755-63. PubMed ID: 17329070
[TBL] [Abstract][Full Text] [Related]
7. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
[TBL] [Abstract][Full Text] [Related]
8. [Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society].
Mata-Cases M; Artola S; Escalada J; Ezkurra-Loyola P; Ferrer-García JC; Fornos JA; Girbés J; Rica I;
Semergen; 2015; 41(5):266-78. PubMed ID: 25752863
[TBL] [Abstract][Full Text] [Related]
9. [Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society].
Mata-Cases M; Artola S; Escalada J; Ezkurra-Loyola P; Ferrer-García JC; Fornos JA; Girbés J; Rica I;
Endocrinol Nutr; 2015 Mar; 62(3):e23-36. PubMed ID: 25648701
[TBL] [Abstract][Full Text] [Related]
10. [Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society].
Mata-Cases M; Artola S; Escalada J; Ezkurra-Loyola P; Ferrer-García JC; Fornos JA; Girbés J; Rica I;
Aten Primaria; 2015; 47(7):456-68. PubMed ID: 25735589
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and medical management of benign prostatic hyperplasia.
Beckman TJ; Mynderse LA
Mayo Clin Proc; 2005 Oct; 80(10):1356-62. PubMed ID: 16212149
[TBL] [Abstract][Full Text] [Related]
12. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.
Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M
Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951
[TBL] [Abstract][Full Text] [Related]
13. The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.
Roehrborn CG; Siami P; Barkin J; Damião R; Becher E; Miñana B; Mirone V; Castro R; Wilson T; Montorsi F;
Eur Urol; 2009 Feb; 55(2):461-71. PubMed ID: 19013011
[TBL] [Abstract][Full Text] [Related]
14. 5α-Reductase inhibitor is less effective in men with small prostate volume and low serum prostatic specific antigen level.
Lin VC; Liao CH; Wang CC; Kuo HC
J Formos Med Assoc; 2015 Sep; 114(9):865-71. PubMed ID: 24064231
[TBL] [Abstract][Full Text] [Related]
15. [Consensus on hereditary cancer between the Spanish Oncology Society and the primary care societies].
Robles L; Balmaña J; Barrel I; Grandes S; Graña B; Guillén C; Marcos H; Ramírez D; Redondo E; Sánchez J
Semergen; 2013; 39(5):259-66. PubMed ID: 23834976
[TBL] [Abstract][Full Text] [Related]
16. Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial.
Carballido J; Fourcade R; Pagliarulo A; Brenes F; Boye A; Sessa A; Gilson M; Castro R
Int J Clin Pract; 2011 Sep; 65(9):989-96. PubMed ID: 21733048
[TBL] [Abstract][Full Text] [Related]
17. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
[TBL] [Abstract][Full Text] [Related]
18. Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society.
Mata-Cases M; Artola S; Escalada J; Ezkurra-Loyola P; Ferrer-García JC; Fornos JA; Girbés J; Rica I;
Rev Clin Esp (Barc); 2015 Mar; 215(2):117-29. PubMed ID: 25553948
[TBL] [Abstract][Full Text] [Related]
19. Practice patterns regarding prostate cancer and benign prostatic hyperplasia in Japanese primary care practitioners.
Fukagai T; Maruyama K; Nagata M; Morita M; Naoe M; Yoshida H
Int J Urol; 2007 May; 14(5):412-5. PubMed ID: 17511723
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
